The NAFLD patients were more likely to have diabetes mellitus and had higher AST, ALT, GGT, TG, LDL-C, GLU, URIC, and lower HDL-C than that of non-NAFLD patients (all p < 0.05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.